BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6818036)

  • 1. Effect of vitamin B6 administration on elevated plasma oxalic acid levels in haemodialysed patients.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Eur J Clin Invest; 1982 Dec; 12(6):481-3. PubMed ID: 6818036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of elevated plasma oxalic acid by pyridoxine therapy in patients on RDT.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H
    Proc Eur Dial Transplant Assoc; 1983; 19():308-12. PubMed ID: 6878246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oxalic acid metabolism in chronic renal failure].
    Balcke P
    Wien Klin Wochenschr Suppl; 1985; 160():1-15. PubMed ID: 3859955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary oxalosis in chronic renal insufficiency].
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Z Urol Nephrol; 1982 Jun; 75(6):409-14. PubMed ID: 7124142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pyridoxine supplementation on plasma oxalate concentrations in patients receiving dialysis.
    Tomson CR; Channon SM; Parkinson IS; Sheldon WS; Ward MK; Laker MK
    Eur J Clin Invest; 1989 Apr; 19(2):201-5. PubMed ID: 2499479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary hyperoxalemia in chronic renal failure.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Int J Artif Organs; 1982 May; 5(3):141-3. PubMed ID: 7107047
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro synthesis of oxalic acid has no relevant influence on plasma oxalic acid levels in haemodialysis patients.
    Balcke P; Schmidt P; Zazgornik J; Haubenstock A; Kopsa H
    J Clin Chem Clin Biochem; 1984 Mar; 22(3):261-3. PubMed ID: 6726124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hyperoxalaemia on factor VIII-related antigen in uremia.
    Tomson CR; Channon SM; Ward MK; Hamilton PJ; Oxley A; Laker MF
    Nephron; 1990; 54(3):276. PubMed ID: 2314548
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of vitamin B6 supplementation on plasma oxalate and oxalate removal rate in hemodialysis patients.
    Costello JF; Sadovnic MC; Smith M; Stolarski C
    J Am Soc Nephrol; 1992 Oct; 3(4):1018-24. PubMed ID: 1450364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C, and vitamin B6 during continuous ambulatory peritoneal dialysis.
    Mydlík M; Derzsiová K; Svác J; Dlhopolcek P; Zemberová E
    Artif Organs; 1998 Sep; 22(9):784-8. PubMed ID: 9754466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients.
    Ono K
    Clin Nephrol; 1986 Nov; 26(5):239-43. PubMed ID: 3802587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients.
    Shah GM; Ross EA; Sabo A; Pichon M; Reynolds RD; Bhagavan H
    Am J Kidney Dis; 1992 Jul; 20(1):42-9. PubMed ID: 1621677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascorbate-induced hyperoxalaemia has no significant effect on lactate generation or erythrocyte 2,3,diphosphoglycerate in dialysis patients.
    Tomson CR; Channon SM; Ward MK; Laker MF
    Eur J Clin Invest; 1990 Aug; 20(4):411-5. PubMed ID: 2121500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridoxine therapy in patients with renal calcium oxalate calculi.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Minar E
    Proc Eur Dial Transplant Assoc; 1983; 20():417-21. PubMed ID: 6657665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oxalic acid--important uremic toxin].
    Mydlík M; Derzsiová K
    Vnitr Lek; 2010 Jul; 56(7):695-701. PubMed ID: 20842915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The determination of plasma oxalate concentrations using an enzyme/bioluminescent assay.
    Parkinson IS; Kealey T; Laker MF
    Clin Chim Acta; 1985 Nov; 152(3):335-45. PubMed ID: 4064338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis.
    Rolton HA; McConnell KM; Modi KS; Macdougall AI
    Nephrol Dial Transplant; 1991; 6(6):440-3. PubMed ID: 1876286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin B6 status in uremia.
    Laso Guzmán FJ; González-Buitrago JM; Vela R; Cava F; de Castro S
    Klin Wochenschr; 1990 Feb; 68(3):183-6. PubMed ID: 2314006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intra-erythrocytic GOT activity in uremia and its behavior following pyridoxine administration].
    Balcke P; Schmidt P; Zazgornik J; Kopsa H
    Klin Wochenschr; 1983 Sep; 61(17):859-63. PubMed ID: 6632728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.